Cas:355837-47-7 (2,2-dimethyl-3,4-dihydrochromen-8-yl)methanol manufacturer & supplier

We serve Chemical Name:(2,2-dimethyl-3,4-dihydrochromen-8-yl)methanol CAS:355837-47-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(2,2-dimethyl-3,4-dihydrochromen-8-yl)methanol

Chemical Name:(2,2-dimethyl-3,4-dihydrochromen-8-yl)methanol
CAS.NO:355837-47-7
Synonyms:(2,2-dimethyl-3,4-dihydrochromen-8-yl)methanol
Molecular Formula:C12H16O2
Molecular Weight:192.25400
HS Code:2932999099

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:29.46000
Exact Mass:192.11500
LogP:2.28250

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (2,2-dimethyl-3,4-dihydrochromen-8-yl)methanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2,2-dimethyl-3,4-dihydrochromen-8-yl)methanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(2,2-dimethyl-3,4-dihydrochromen-8-yl)methanol Use and application,(2,2-dimethyl-3,4-dihydrochromen-8-yl)methanol technical grade,usp/ep/jp grade.


Related News: MSD – known as Merck in the US and Canada – is jointly developing Verquvo with Bayer. While MSD hold the commercial rights to the heart failure med in the US, Bayer has the exclusive commercial rights in the rest of the world. (1E,3E,5R,6R,7R,8R,9S)-8-((tert-butyldimethylsilyl)oxy)-3,5,7,9-tetramethyl-1-(tributylstannyl)undeca-1,3-dien-6-ol manufacturers Considering that small batches present a challenge in proving the robustness of the processing equipment, the Alcami project team, in collaboration with client team members, prepared a failure mode, effects, and criticality analysis (FMECA) of the formulation and process. N,N-dimethyl-2-(5-methyl-2-phenylindol-3-yl)ethylamine suppliers “Partnering with a CDMO that has the skills and capabilities to execute a successful tech transfer is critical, as this complex, multi-step process helps lay the foundation for the new drug’s journey through to commercialization. 9,10-Dimethyl-Δ4a(4b)-dodecahydrophenanthren-9-carbonsaeure vendor & factory.